查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1996547

胃食道逆流症治療設備市場：依產品類型、治療類型、最終用戶和通路分類－2026-2032年全球預測

Gastroesophageal Reflux Disease Devices Market by Product Type, Procedure Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，胃食道逆流症 (GERD) 治療設備市場價值將達到 11.5 億美元，到 2026 年將成長至 12.2 億美元，到 2032 年將達到 20.8 億美元，複合年成長率為 8.81%。

主要市場統計數據
基準年 2025 11.5億美元
預計年份：2026年 12.2億美元
預測年份 2032 20.8億美元
複合年成長率 (%) 8.81%

全面概述胃食道逆流症 (GERD) 治療設備的發展趨勢以及推動快速創新的臨床和商業性因素。

胃食道逆流症 (GERD) 仍然是一種具有重要臨床意義的疾病，持續推動內視鏡、磁振造影、射頻和外科手術等多種治療方法和醫療設備的創新發展。臨床醫生和醫療系統日益需要能夠減少長期藥物依賴、最大限度降低圍手術全期風險並實現門診治療的干涉措施。因此，醫療設備的發展趨勢呈現出快速迭代改進、日益關注以患者為中心的治療結果以及針對門診治療最佳化技術的湧現等特點。

本文詳細探討了正在重塑胃食道逆流症相關醫療設備引入和醫療保健提供者決策的臨床、技術和商業性變革。

由於微創平台的治療方法、磁性括約肌增強技術的成熟以及口腔和內視鏡縫合技術的改進，用於治療胃食道逆流 (GERD) 的器材市場正在經歷一場變革。臨床醫生正在採用兼顧症狀控制和解剖結構保護的治療方法，而器械開發商也在積極響應，推出改進型產品，優先考慮易於實施、可重複性以及減少術中和術後併發症。

對美國在 2025 年實施的累積關稅如何重塑供應鏈、採購方式和醫療設備商業化策略進行策略分析。

2025年生效的美國新關稅的累積影響，正在重塑整個胃食道逆流（GERD）治療設備生態系統的供應鏈動態、零件採購決策和定價模式。依賴進口零件（例如精密導管、磁性材料和微電子元件）的醫療設備製造商正面臨不斷上漲的到貨成本，這加速了他們對材料清單（BOM）最佳化和國內及近岸供應商評估的重新審視。因此，採購團隊正優先考慮雙重採購、長期供應商合約以及增加庫存緩衝，以降低成本波動和前置作業時間不確定性。

實用的細分洞察，揭示產品架構、臨床環境和通路如何影響競爭定位和採用趨勢。

細分市場層面的趨勢揭示了產品類型、終端用戶和通路之間的顯著差異，從而為產品開發重點和商業規劃提供了直接的見解。在產品類型細分方面，內視鏡縫合器材正在不斷發展，競爭性的縫合系統和成熟的平台（如Overstitch）都優先考慮更小的輸送尺寸和更高的組織整合一致性。同時，磁性括約肌增強產品也不斷演進，從第一代設計發展到專注於可調節性、MRI相容性和簡化植入流程的下一代系統。射頻消融術器械透過先進的導管系統進行定位，強調病灶控制和能量調節，這與以成本和易用性為主要考慮因素的標準導管系統形成對比。在胃底折疊手術領域，機器人輔助腹腔鏡系統憑藉其更佳的操作性和可視性，正與傳統腹腔鏡系統並駕齊驅，儘管這需要不同的資本投入和培訓投入。成熟的系統（如 Esophyx）和新興的下一代胃底折疊解決方案（代表經口非切口胃底折疊平台）在手術時間、解剖修復耐久性和門診手術適用性方面展開競爭。

重點區域洞察，闡述美洲、歐洲、中東和非洲以及亞太地區的市場動態如何影響法規、臨床實務和供應鏈策略。

區域趨勢對美洲、歐洲、中東、非洲和亞太市場的監管路徑、臨床部署模式和供應鏈韌性有顯著影響。在美洲，強大的醫院網路和不斷擴大的門診手術中心容量為在門診環境中展現療效和可靠臨床證據的醫療器械提供了支持。同時，在採購週期和與保險公司的談判中，對整體醫療保健的成本節約效果是關鍵考慮因素。該地區也是下一代系統早期商業化的中心，臨床醫生和學術機構檢驗其臨床效用。

重點闡述公司層面的關鍵洞察，重點介紹平台策略、夥伴關係、臨床證據和售後服務如何決定 GERD 設備市場的競爭優勢。

胃食道逆流 (GERD) 器材市場的競爭格局受到多種因素的影響，包括成熟的醫療設備公司、高度專業化的新興企業以及專注於平台擴充性和臨床整合的跨產業技術合作夥伴。主要企業正投資於模組化平台策略，以實現功能上的漸進式升級，而無需徹底改造硬體，從而縮短產品迭代周期並減輕監管負擔。同時，小規模的創新者正透過解決特定的臨床挑戰（例如器械小型化、簡化部署和改進術後監測）在細分市場站穩腳跟。

為領導者提供有針對性、可操作的建議，以加強供應鏈、證據生成、培訓計劃和經營模式，從而加速採用並保護利潤率。

產業領導者應優先採取一系列切實可行的行動措施，以克服當前不利因素並抓住新的機會。首先，他們應透過多元化零件採購和考慮將關鍵子組裝流程外包，來降低關稅風險並減少前置作業時間波動。在增強價值鏈韌性的同時，他們還應投資產生符合支付方終點和醫院估值框架的臨床證據，重點關注耐用性、生活品質 (QOL) 測量和成本抵消分析，以支持在門診和住院環境中的部署。

高度透明和嚴謹的調查方法，結合了對臨床醫生和採購負責人的初步訪談、整合的臨床和監管資訊以及供應鏈映射。

本分析的調查方法結合了結構化的原始研究和嚴謹的二手研究，並採用迭代檢驗，以確保其可靠性和可操作性。原始研究包括對臨床醫生、採購經理、供應鏈經理和行業高管進行結構化訪談，以了解設備在真實臨床環境中的表現、應用障礙和採購偏好。二手研究包括對同行評審的臨床文獻、監管申報文件、程序規範指南和公開的技術摘要進行系統性回顧，以將設備功能集與臨床終點進行映射。

總而言之，整合凸顯了協調臨床證據、供應鏈韌性和適應性商業化以主導GERD 設備普及的必要性。

總而言之，胃食道逆流 (GERD)醫療設備市場正處於轉折點，其促進因素包括技術進步、門診治療模式的轉變以及支付方期望的改變。那些將產品開發與可證實的臨床價值相結合、投資於全面的培訓和售後服務項目並建立穩健供應鏈的製造商，將更有利於最大限度地利用向微創、以門診為中心的治療路徑累積所帶來的益處。儘管關稅環境和區域監管差異增加了市場的複雜性，但也為企業提供了將生產轉移到國內和建立戰略夥伴關係關係的獎勵，從而能夠獲得競爭優勢。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：胃食道逆流症治療器材市場：依產品類型分類

  • 內視鏡縫合裝置
    • 相互競爭的縫合系統
    • 包縫系統
  • 磁性括約肌增強裝置
    • 第一代系統
    • 下一代系統
  • 射頻消融術裝置
    • 先進的導管系統
    • 標準導管系統
  • 外科胃底折疊裝置
    • 傳統腹腔鏡系統
    • 機器人輔助腹腔鏡系統
  • 無需口腔切口的胃底折疊裝置
    • 腦下垂體系統
    • 新一代胃底折疊手術系統

第9章：胃食道逆流症治療器材市場－依治療類型分類

  • 診斷治療
  • 治療
    • 內視鏡手術
      • 組織增厚
    • 手術治療
      • 腹腔鏡胃底折疊術
      • 電刺激療法
  • 監測措施
    • 短期住院監測
    • 長期門診監測

第10章：胃食道逆流症治療設備市場：依最終用戶分類

  • 門診手術中心
    • 獨立設施
    • 醫院附設設施
  • 診所
    • 基層醫療診所
    • 專科診所
  • 醫院
    • 綜合醫院
    • 專業醫療中心
      • 胃腸病專科中心
      • 多專科醫療中心

第11章：胃食道逆流症治療器材市場：依分銷管道分類

  • 直銷
  • 線上銷售
    • EC平台
    • 製造商門戶
  • 第三方經銷商
    • 全國銷售代理
    • 區域銷售代理

第12章：胃食道逆流症治療器材市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：胃食道逆流症治療器材市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：胃食道逆流症治療器材市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國胃食道逆流症治療器材市場

第16章：中國胃食道逆流症治療器材市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Diversatek Healthcare, Inc.
  • EndoGastric Solutions, Inc.
  • Fujifilm Holdings Corporation
  • GI Dynamics, Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Koninklijke Philips NV
  • Laborie Medical Technologies Corp.
  • Mederi Therapeutics, Inc.
  • Medtronic plc
  • Olympus Corporation
  • Pentax Medical
  • Stryker Corporation
  • Torax Medical, Inc.
Product Code: MRR-925E8149CEF2

The Gastroesophageal Reflux Disease Devices Market was valued at USD 1.15 billion in 2025 and is projected to grow to USD 1.22 billion in 2026, with a CAGR of 8.81%, reaching USD 2.08 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.15 billion
Estimated Year [2026] USD 1.22 billion
Forecast Year [2032] USD 2.08 billion
CAGR (%) 8.81%

A comprehensive introduction to the evolving gastroesophageal reflux disease device landscape and the clinical and commercial forces driving rapid innovation

Gastroesophageal reflux disease remains a clinically significant condition that continues to shape procedural innovation and device development across endoscopic, magnetic, radiofrequency, and surgical approaches. Clinicians and health systems are increasingly seeking interventions that reduce long-term medication dependence, minimize perioperative risk, and enable same-day pathways. As a result, the device landscape is characterized by rapid iteration, a heightened focus on patient-centric outcomes, and the emergence of outpatient-optimized technologies.

In parallel, payer scrutiny and hospital procurement cycles are shaping adoption curves, while clinical evidence requirements for safety and durability are becoming more rigorous. Transitioning care away from inpatient admissions toward ambulatory surgical centers and specialized clinics is exerting pressure on device manufacturers to deliver compact, cost-effective, and interoperable systems that integrate with existing operating room technology stacks. Consequently, commercial and clinical leaders must navigate an environment where technological promise must be matched by reproducible clinical performance and viable reimbursement strategies.

An in-depth look at the transformative clinical, technological, and commercial shifts reshaping GERD device adoption and provider decision-making

The landscape for gastroesophageal reflux disease devices is undergoing transformative shifts driven by procedural migration to minimally invasive platforms, the maturation of magnetic sphincter augmentation concepts, and the refinement of transoral and endoscopic suturing techniques. Clinicians are adopting approaches that seek to balance symptom control with anatomical preservation, and device developers are responding with iterations that prioritize ease of deployment, reproducibility, and reduced periprocedural morbidity.

Moreover, surgical fundoplication is evolving through greater use of robotic assistance and enhanced imaging, while radiofrequency ablation systems are differentiating on catheter design and energy delivery precision. These technology advances are occurring alongside broader healthcare system trends such as outpatient care expansion, value-based contracting, and greater emphasis on health economics. Consequently, market participants are compelled to align clinical evidence generation with user training programs and to redesign commercial models to support diverse end users, including freestanding ambulatory centers, hospital-affiliated facilities, and specialty clinics. This period of transformation therefore favors organizations that couple engineering agility with robust clinical validation and adaptive go-to-market strategies.

A strategic analysis of how the cumulative United States tariffs introduced in 2025 are restructuring supply chains, procurement behaviors, and device commercialization strategies

The cumulative effects of new United States tariffs enacted in 2025 are reshaping supply chain strategies, component sourcing decisions, and pricing dynamics across the gastroesophageal reflux disease device ecosystem. Device manufacturers that rely on imported specialty components such as precision catheters, magnetic materials, or microelectronics are experiencing higher landed costs, prompting reassessment of bill-of-materials optimization and accelerated evaluation of domestic or nearshore suppliers. As a result, procurement teams are prioritizing dual-sourcing, longer-term supplier agreements, and increased inventory buffers to mitigate cost volatility and lead-time uncertainty.

In addition, tariff-driven cost pressures are influencing go-to-market choices, with some manufacturers electing to absorb incremental costs to preserve competitive pricing while others are introducing differentiated service bundles to maintain margin. Hospitals and ambulatory surgical centers are responding by intensifying capital allocation reviews and demanding clearer total-cost-of-care narratives from device vendors. The tariff environment is also catalyzing investment in localized assembly and testing capabilities, which reduces exposure to import duties and can shorten regulatory submission timelines for incremental device iterations. Finally, payers and health systems are watching these developments closely, increasingly tying reimbursement conversations to demonstrable value and long-term cost offsets rather than upfront device price alone.

Actionable segmentation insights revealing how product architectures, clinical settings, and distribution pathways influence competitive positioning and adoption dynamics

Segment-level dynamics reveal meaningful differentiation across product types, end users, and distribution avenues that directly inform product development priorities and commercial planning. Within product type segmentation, endoscopic suturing devices are evolving with competitive suturing systems and established Overstitch-like platforms prioritizing smaller-profile delivery and improved tissue apposition consistency, while magnetic sphincter augmentation offerings continue to advance from first generation designs toward next generation systems that focus on adjustability, MRI compatibility, and simplified implantation workflows. Radiofrequency ablation devices are being positioned through advanced catheter systems that emphasize lesion control and energy modulation versus standard catheter systems where cost and ease of use remain dominant considerations. In the surgical fundoplication space, conventional laparoscopic systems are increasingly complemented by robotic assisted laparoscopic systems that offer enhanced dexterity and visualization but require different capital and training commitments. Transoral incisionless fundoplication platforms, represented by entrenched Esophyx-like systems and emergent next generation fundoplication solutions, are competing on procedure time, durability of anatomical repair, and outpatient readiness.

End user segmentation further nuances purchasing behavior and clinical pathways. Ambulatory surgical centers, including both freestanding centers and hospital-affiliated centers, are gravitating toward devices that support short-stay or same-day discharge protocols and that minimize capital footprint. Clinics, whether primary care clinics or specialty clinics, are more selective in device adoption, often focusing on referral networks and diagnostic-to-procedure continuity. Hospitals, including general hospitals and specialty centers, tend to balance surgical volume considerations against training capacity, with gastroenterology specialty centers and multispecialty centers each prioritizing different procedural mixes and post-procedure support models. Distribution channel segmentation highlights that direct sales remain the preferred route for high-touch device adoption, whereas online sales through e-commerce platforms and manufacturer portals are growing for consumables and adjunct tools, and third party distributors, both national and regional, continue to play an essential role in extending reach into varied clinical settings. Collectively, these segmentation insights underscore the need for manufacturers to tailor product feature sets, training programs, and channel strategies to the specific economics and operational constraints of each buyer cohort.

Critical regional insights describing how Americas, Europe Middle East & Africa, and Asia-Pacific market dynamics shape regulatory, clinical, and supply chain strategies

Regional dynamics materially influence regulatory pathways, clinical adoption patterns, and supply chain resilience across the Americas, Europe Middle East & Africa, and Asia-Pacific markets. In the Americas, strong hospital networks and growing ambulatory surgical center capacity favor devices that demonstrate outpatient efficacy and robust clinical evidence, while procurement cycles and payer negotiations place emphasis on demonstrable reductions in total cost of care. This region also serves as a focal point for early commercial launches of next generation systems, where clinician champions and academic centers validate clinical utility.

In Europe Middle East & Africa, regulatory heterogeneity and fragmented reimbursement frameworks mean that market entry strategies must be tailored to country-specific clinical guidelines and procurement practices. Here, value dossiers that address health economic evaluations and real-world evidence can accelerate uptake, particularly in specialty centers that emphasize minimally invasive care. In the Asia-Pacific region, rapid investment in healthcare infrastructure and an expanding base of trained endoscopists and surgeons are driving interest in cost-efficient technologies and scalable training models. Manufacturing and assembly footprints in this region also act as strategic anchors for companies seeking to diversify supply chains and reduce exposure to import tariffs, while local clinical studies and partnerships with regional opinion leaders can meaningfully influence adoption.

Key company-level insights highlighting how platform strategies, partnerships, clinical evidence, and aftermarket services determine competitive advantage in the GERD devices market

Competitive dynamics in the gastroesophageal reflux disease device arena are influenced by a mix of established medical device organizations, specialized emerging firms, and cross-sector technology partners focused on platform scalability and clinical integration. Leading players are investing in modular platform strategies that enable incremental feature upgrades without wholesale reinvention of hardware, thereby shortening product iteration cycles while managing regulatory burden. Concurrently, smaller innovators are carving niche positions by solving specific clinical pain points such as device profile reduction, simplified deployment, or improved post-procedure monitoring.

Strategic partnerships and selective acquisitions are common as companies seek to combine clinical credibility with commercialization scale, and aftermarket services-such as procedural training, proctoring, and disposable consumable programs-are increasingly important revenue and retention levers. Intellectual property portfolios and the depth of clinical evidence are crucial differentiators that influence hospital formulary decisions and payer discussions. Finally, companies that integrate digital health capabilities, patient-reported outcome tracking, and remote follow-up tools are more likely to secure long-term contracts with health systems seeking comprehensive care pathways rather than standalone devices.

Targeted and practical recommendations for leaders to fortify supply chains, evidence generation, training programs, and commercial models to accelerate adoption and protect margin

Industry leaders should prioritize a set of practical, execution-focused actions to navigate current headwinds and capture emerging opportunities. First, diversify component sourcing and consider nearshoring critical subassembly processes to mitigate tariff exposure and reduce lead-time variability. Parallel to supply chain resilience, invest in clinical evidence generation that aligns with payer endpoints and hospital value frameworks, focusing on durability, quality-of-life measures, and cost-offset analyses that support adoption across ambulatory and hospital settings.

Second, design training and proctoring programs that lower the procedural learning curve and enable rapid scale within ambulatory surgical centers and specialty clinics, thereby expanding addressable use cases. Third, adopt flexible commercial models that combine direct sales for high-touch conversions with expanded e-commerce and distributor partnerships for consumables and adjuncts, while negotiating bundled pricing or subscription approaches that align incentives with long-term outcomes. Fourth, accelerate development of next generation device features such as MRI-safe materials, adjustable magnetic constructs, and advanced catheter control to differentiate product roadmaps. Fifth, engage proactively with regulators and payers to streamline coverage pathways and to influence clinical guideline inclusion. Finally, implement scenario planning for tariff shifts and reimbursement changes to ensure pricing agility and to preserve investments in R&D and clinician engagement.

A transparent and rigorous research methodology combining primary clinician and procurement interviews with secondary clinical and regulatory synthesis and supply chain mapping

The research methodology underpinning this analysis combines structured primary inquiry with rigorous secondary synthesis and iterative validation to ensure credibility and actionable relevance. Primary research involved structured interviews with clinicians, procurement leaders, supply chain managers, and industry executives to capture real-world device performance, adoption barriers, and procurement preferences. Secondary research included systematic review of peer-reviewed clinical literature, regulatory filings, procedure coding guidelines, and publicly available technology briefs to map device feature sets and clinical endpoints.

Data triangulation was applied by cross-referencing interview insights with regulatory documentation and manufacturer technical specifications. Supply chain mapping leveraged trade flows, component sourcing patterns, and manufacturing footprint analyses to interpret tariff impacts and logistical constraints. Quality control measures included peer review by clinical experts and methodologists, reconciliation of divergent viewpoints, and transparent documentation of assumptions. Limitations are acknowledged where regional data gaps exist or where long-term durability evidence is still maturing, and the report recommends periodic updates as additional real-world evidence and regulatory decisions become available.

Concluding synthesis emphasizing the imperative to align clinical evidence, supply chain resilience, and adaptive commercialization to lead in GERD device adoption

In summary, the gastroesophageal reflux disease device market is at an inflection point driven by technological refinement, procedural migration to ambulatory settings, and evolving payer expectations. Manufacturers that align product development with demonstrable clinical value, invest in robust training and aftercare programs, and build resilient supply chains will be best positioned to capitalize on the shift toward minimally invasive and outpatient-centric care pathways. The cumulative tariff environment and regional regulatory heterogeneity add complexity, but they also create incentives for onshoring and strategic partnerships that can yield competitive advantage.

Ultimately, success will hinge on the ability to translate clinical promise into reproducible outcomes, to present clear value propositions to payers and providers, and to execute adaptable commercial models that reflect the operational realities of ambulatory surgical centers, clinics, and hospitals. Stakeholders who combine clinical rigor, supply chain foresight, and customer-centric commercialization will lead the next wave of adoption and shape long-term standards of care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastroesophageal Reflux Disease Devices Market, by Product Type

  • 8.1. Endoscopic Suturing Devices
    • 8.1.1. Competitor Suturing Systems
    • 8.1.2. Overstitch Systems
  • 8.2. Magnetic Sphincter Augmentation Devices
    • 8.2.1. First Generation Systems
    • 8.2.2. Next Generation Systems
  • 8.3. Radiofrequency Ablation Devices
    • 8.3.1. Advanced Catheter Systems
    • 8.3.2. Standard Catheter Systems
  • 8.4. Surgical Fundoplication Devices
    • 8.4.1. Conventional Laparoscopic Systems
    • 8.4.2. Robotic Assisted Laparoscopic Systems
  • 8.5. Transoral Incisionless Fundoplication Devices
    • 8.5.1. Esophyx Systems
    • 8.5.2. Next Generation Fundoplication Systems

9. Gastroesophageal Reflux Disease Devices Market, by Procedure Type

  • 9.1. Diagnostic Procedures
  • 9.2. Therapeutic Procedures
    • 9.2.1. Endoscopic Procedures
      • 9.2.1.1. Tissue Bulking Procedures
    • 9.2.2. Surgical Procedures
      • 9.2.2.1. Laparoscopic Fundoplication Procedures
      • 9.2.2.2. Electrical Stimulation Procedures
  • 9.3. Monitoring Procedures
    • 9.3.1. Short-Term In-Hospital Monitoring
    • 9.3.2. Long-Term Ambulatory Monitoring

10. Gastroesophageal Reflux Disease Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Freestanding Centers
    • 10.1.2. Hospital Affiliated Centers
  • 10.2. Clinics
    • 10.2.1. Primary Care Clinics
    • 10.2.2. Specialty Clinics
  • 10.3. Hospitals
    • 10.3.1. General Hospitals
    • 10.3.2. Specialty Centers
      • 10.3.2.1. Gastroenterology Specialty Centers
      • 10.3.2.2. Multispecialty Centers

11. Gastroesophageal Reflux Disease Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online Sales
    • 11.2.1. E Commerce Platforms
    • 11.2.2. Manufacturer Portals
  • 11.3. Third Party Distributors
    • 11.3.1. National Distributors
    • 11.3.2. Regional Distributors

12. Gastroesophageal Reflux Disease Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Gastroesophageal Reflux Disease Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Gastroesophageal Reflux Disease Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Gastroesophageal Reflux Disease Devices Market

16. China Gastroesophageal Reflux Disease Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. B. Braun Melsungen AG
  • 17.6. Becton, Dickinson and Company
  • 17.7. Boston Scientific Corporation
  • 17.8. Cook Medical LLC
  • 17.9. Diversatek Healthcare, Inc.
  • 17.10. EndoGastric Solutions, Inc.
  • 17.11. Fujifilm Holdings Corporation
  • 17.12. GI Dynamics, Inc.
  • 17.13. Intuitive Surgical, Inc.
  • 17.14. Johnson & Johnson
  • 17.15. KARL STORZ SE & Co. KG
  • 17.16. Koninklijke Philips N.V.
  • 17.17. Laborie Medical Technologies Corp.
  • 17.18. Mederi Therapeutics, Inc.
  • 17.19. Medtronic plc
  • 17.20. Olympus Corporation
  • 17.21. Pentax Medical
  • 17.22. Stryker Corporation
  • 17.23. Torax Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TISSUE BULKING PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TISSUE BULKING PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TISSUE BULKING PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LAPAROSCOPIC FUNDOPLICATION PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LAPAROSCOPIC FUNDOPLICATION PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LAPAROSCOPIC FUNDOPLICATION PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SHORT-TERM IN-HOSPITAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SHORT-TERM IN-HOSPITAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SHORT-TERM IN-HOSPITAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LONG-TERM AMBULATORY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LONG-TERM AMBULATORY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LONG-TERM AMBULATORY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET S